You are viewing one comment and its replies. View all comments
LOL…experimental in mice, meanwhile, The CIM in Cuba already trialed and approved a nasal delivered drug for Alzheimers and Americans are sneaking over to buy it.
$25 for 10 doses -this is unacceptable for USA, so it needs to be reinvented and sold for $25,000/yr.
For those interested it was the athenea trial and was approved in 2023. Two year follow up shows AD progression is still slowed in 2025.
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer’s clinical syndrome: the ATHENEA randomized clinical trial - PubMed https://share.google/5eaJS93aAPZnIVNBR
Is there a non-google link?
Direct link to PubMed article
Champion thanks 🏅
Sign in to comment. Sign in
Comments
LOL…experimental in mice, meanwhile, The CIM in Cuba already trialed and approved a nasal delivered drug for Alzheimers and Americans are sneaking over to buy it.
$25 for 10 doses -this is unacceptable for USA, so it needs to be reinvented and sold for $25,000/yr.
For those interested it was the athenea trial and was approved in 2023. Two year follow up shows AD progression is still slowed in 2025.
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer’s clinical syndrome: the ATHENEA randomized clinical trial - PubMed https://share.google/5eaJS93aAPZnIVNBR
Is there a non-google link?Direct link to PubMed article
Champion thanks 🏅
Sign in to comment. Sign in